Pirlimycin hydrochloride

This classification denotes a lincosamide antibiotic with the molecular formula C17H31ClN2O5S.ClH.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8S09O559AQ, chemically known as l-threo-.alpha.-d-galacto-octopyranoside, methyl 7-chloro-6,7,8-trideoxy-6-(((4-ethyl-2-piperidinyl)carbonyl)amino)-1-thio-, monohydrochloride, monohydrate, (2s-cis)-, but more generally known as pirlimycin hydrochloride, which bears US NIH Compound Identifier 71997. European Medicines Agency schedules pirlimycin hydrochloride or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09922MIG. Most nations, for tariff purposes, schedule pirlimycin hydrochloride under HS 29419000. Pirlimycin hydrochloride bears US NLM identifiers UMLS ID C0521904 and NCI Concept Code C73846. SMILES: CC[C@@H]1CCN[C@@H](C1)C(=O)N[C@@H]([C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)SC)O)O)O)[C@H](C)CL.O.CL.